Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.
about
Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trialsPsoriasis (chronic plaque)Novel targeted therapies for eosinophil-associated diseases and allergyBiologics in the management of psoriasis.Novel biological immunotherapies for psoriasis.Psoriasis assessment tools in clinical trials.Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis.Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Depression and quality of life in psoriasis.Biologics in the treatment of psoriasis: clinical and economic overview.Alefacept: where it stands today.Application of the dermatology life quality index in clinical trials of biologics for psoriasis.Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.Cost effectiveness of biologic therapies for plaque psoriasis.A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.Post-trauma growth in a mainland Chinese population with chronic skin disease.Cost-effectiveness and impact on quality of life of alefacept in the treatment of psoriasis.The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis.Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2.Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
P2860
Q24791176-25179DC1-5462-4087-B32B-3BE79AB55E21Q34010557-9A29A74D-6241-497B-B6D8-9643F55F2837Q34444620-5AF07711-F4DA-49D5-9DAA-52F923D23707Q34620257-936F5501-1DEB-4816-A3E9-1331D818E635Q35164740-87E68BDA-547B-4B99-88FD-B33D21F27960Q35579443-D6481B34-613E-4F77-91F0-5E392DC6C147Q36216535-B5E36817-4F2E-4A32-B4EB-B1604CA9D035Q36356951-DB20B94D-B29A-4843-8A66-5ECD997AABA2Q36661303-08769B6B-1259-4B8E-BA4A-C2A4EC3E5D35Q36827134-12D37844-FA83-4E63-920F-41611DAEC9D9Q37566094-63D56A9D-3443-4A44-B01D-C422F05B5B8CQ37607414-0B2DFBFB-F893-463B-B518-B104E212C52DQ37693964-9F991132-FC17-4128-8A11-8D294DB90339Q37998917-CB761185-4EC0-4C47-9D30-D0FA347B49E3Q38083089-ADA40AB2-09DD-41C9-ACF0-B6FAA20E22D5Q38108567-B0CEDF0E-1E59-4121-A7F9-5B73A0A341FBQ38858335-31F065E7-7C9F-4FE9-8A99-74295109DB31Q39263305-A0C7EA33-F610-4E9D-9088-78AF740C940CQ43042832-0D28BCE5-C54E-417E-AAF4-E6B0665A9FC5Q46240751-C0EC561D-58A3-40B3-864C-1676168273D8Q47260366-4AF2B7C9-C69F-4AFB-A31E-3374241C9FF6Q48566723-00A9A0C2-AADE-47B4-980F-511A2D837100Q48776801-005729F0-D70A-4C6B-862F-5B518D06303FQ51917360-4615DAF5-21F1-488B-A205-E36EDF53E905
P2860
Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effects of alefacept on health ...... ebo-controlled phase II trial.
@en
Effects of alefacept on health ...... ebo-controlled phase II trial.
@nl
type
label
Effects of alefacept on health ...... ebo-controlled phase II trial.
@en
Effects of alefacept on health ...... ebo-controlled phase II trial.
@nl
prefLabel
Effects of alefacept on health ...... ebo-controlled phase II trial.
@en
Effects of alefacept on health ...... ebo-controlled phase II trial.
@nl
P2093
P921
P1476
Effects of alefacept on health ...... ebo-controlled phase II trial.
@en
P2093
Charles N Ellis
Ellen Y Adler
Margaret M Mordin
Randomized, placebo-controlled phase II trial
P304
P356
10.2165/00128071-200304020-00005
P577
2003-01-01T00:00:00Z
P6179
1008951199